Fenwick & West has represented Achieve Life Sciences, Inc., and Freshfields has advised Morgan Stanley as sole placement agent. Achieve Life Sciences, Inc., a late-stage specialty...
Achieve Life Sciences Secures Up to $354 Million in Private Placement
Maze Therapeutics Announces $150 Million Registered Offering
Fenwick & West has advised Maze Therapeutics. Morrison & Foerster has served as intellectual property counsel for Maze Therapeutics. Davis Polk & Wardwell has advised the...
Wealthfront Completes $484 Million Initial Public Offering
Fenwick & West and Sidley have advised Wealthfront; Latham & Watkins has advised the underwriters; Whalen LLP has advised the selling stockholders. Wealthfront, a technology-driven financial...
Maze Therapeutics Announces $150 Million Private Placement
Fenwick & West has advised Maze Therapeutics. Maze Therapeutics, a clinical-stage biopharmaceutical company, has announced the signing of a securities purchase agreement for an oversubscribed private...
Achieve Life Sciences Announces $45 Million Public Offering
Fenwick has advised Achieve Life Sciences. on the deal, and Ellenoff Grossman & Schole has advised the underwriters. Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage...
Rocket Companies’ $1.75 Billion Acquisition of Redfin
Paul, Weiss, Rifkind, Wharton & Garrison advised Rocket Companies on the transaction, and Fenwick & West advised Redfin. Rocket Companies (NYSE: RKT), the Detroit-based fintech platform...
Maze Therapeutics’ $140 Million Upsized Initial Public Offering
Fenwick & West represented Maze Therapeutics in the offering, and Davis Polk & Wardwell represented the underwriters. Maze Therapeutics, Inc. (Nasdaq: MAZE) announced its upsized initial...
Blackstone and Vista Equity Partners’ $8.4 Billion Acquisition of Smartsheet
Fenwick & West is representing Smartsheet on the transaction, while Kirkland & Ellis and Simpson Thacher & Bartlett are representing Blackstone and Vista Equity Partners. Smartsheet...
Vista Equity Partners’ $1.5 Billion Acquisition of Model N
Kirkland & Ellis is representing Vista Equity Partners in the transaction, and Fenwick & West is representing Model N. Vista Equity Partners, which announced its definitive...
Gritstone bio’s $32.5 Million Common Stock Offering
Fenwick & West and Goodwin Procter represented Gritstone bio, Inc. in the offering, and Cooley represented the underwriters. Gritstone bio, Inc. (Nasdaq: GRTS) announced the pricing of...
Vertex Pharmaceuticals’ Acquisition of Alpine Immune Sciences
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
Achieve Life Sciences’ Direct Offering and Concurrent Private Placement
Fenwick & West represented Achieve Life Sciences, while Sullivan & Worcester represented Lake Street Capital Markets, LLC and JonesTrading Institutional Services LLC on the transaction. Achieve...